Super Investor #31 in our series is Terry Smith – the legendary investor often called the “UK’s Warren Buffett.” As the founder of Fundsmith Equity Fund, Smith has built a reputation for investing in high-quality businesses with strong returns on capital. His long-term, buy-and-hold approach has delivered impressive results, making…
Tag: NVO
How to Compare Two Companies in the Same Industry
Learning How to Compare Two Companies in the Same Industry is a Key Skill for Investors. Investing in the stock market can feel overwhelming, especially when trying to choose between two companies in the same industry. However, understanding how to make these comparisons is one of the most valuable skills an…
Pharmaceutical Giants: Profiting from Health Innovation
The pharmaceutical industry plays a pivotal role in modern society, not only by addressing some of the most pressing health challenges but also as a key driver of economic growth and innovation. For long-term, buy-and-hold investors, this sector offers a unique opportunity to invest in companies at the forefront of…
How Weight-loss Treatments Could Disrupt Other Industries: The Impact of GLP-1 Drugs
The medical landscape is undergoing a seismic shift with the rise of GLP-1 (glucagon-like peptide-1) diabetes and weight-loss treatments. Novo Nordisk’s Ozempic and Wegovy, along with Eli Lilly’s Mounjaro, have been at the forefront of this revolution. These treatments, originally developed for managing type-2 diabetes, have shown remarkable efficacy in…